Synonym
PD 124895; PD-124895; PD124895; Kazusamycin B;
IUPAC/Chemical Name
2,10,12,16,18-Nonadecapentaenoic acid, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15,17-hexamethyl-8-oxo-
InChi Key
OOQHBJFDAPXZJM-VYRSPHQHSA-N
InChi Code
InChI=1S/C32H46O7/c1-20(15-22(3)11-13-28-24(5)12-14-30(36)39-28)9-8-10-21(2)17-27(19-33)32(38)26(7)31(37)25(6)16-23(4)18-29(34)35/h8,10-15,17-18,20,24-28,31,33,37H,9,16,19H2,1-7H3,(H,34,35)/b10-8+,13-11+,21-17+,22-15+,23-18+
SMILES Code
O=C(O)/C=C(C)/CC(C)C(O)C(C)C(C(CO)/C=C(C)/C=C/CC(C)/C=C(C)/C=C/C1C(C)C=CC(O1)=O)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
542.71
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Hurley TR, Bunge RH, Willmer NE, Hokanson GC, French JC. PD 124,895 and PD 124,966, two new antitumor antibiotics. J Antibiot (Tokyo). 1986 Dec;39(12):1651-6. PubMed PMID: 3818438.
2: Funaishi K, Kawamura K, Sugiura Y, Nakahori N, Yoshida E, Okanishi M, Umezawa I, Funayama S, Komiyama K. Kazusamycin B, a novel antitumor antibiotic. J Antibiot (Tokyo). 1987 Jun;40(6):778-85. PubMed PMID: 3610834.
3: Umezawa I, Komiyama K. [Studies on the new antibiotic kazusamycin and related substances]. Gan To Kagaku Ryoho. 1987 Mar;14(3 Pt 2):858-64. Japanese. PubMed PMID: 3105461.
4: Takamiya K, Yoshida E, Takahashi T, Okura A, Okanishi M, Komiyama K, Umezawa I. The effect of kazusamycin B on the cell cycle and morphology of cultured L1210 cells. J Antibiot (Tokyo). 1988 Dec;41(12):1854-61. PubMed PMID: 3209477.
5: Yoshida E, Komiyama K, Naito K, Watanabe Y, Takamiya K, Okura A, Funaishi K, Kawamura K, Funayama S, Umezawa I. Antitumor effect of kazusamycin B on experimental tumors. J Antibiot (Tokyo). 1987 Nov;40(11):1596-604. PubMed PMID: 3693127.